Posted by SLS on September 13, 2023, at 20:16:00
In reply to methylphenidate, posted by gman22 on September 13, 2023, at 18:19:20
> PubMed has several studies showing that for some, methylphenidate monotherapy has produced remission in treatment-resistant subjects.
> Also, patient reviews on several sites have many positive anecdotes.
> I think for me though, it's more effective as an add-on.
>
> https://www.drugs.com/comments/methylphenidate/for-depression.html
Whatever works.I need lithium in my treatment regime to produce a stable, robust antidepressant response. My baseline depression is extremely anergic, with significant memory and cognitive impairments. My thoughts are slowed, and I am numb to my surroundings. I also have intrusive thoughts and negative feelings. The thing is, I require 150 mg/day of lithium for my treatment regime to work. A dosage of 300 mg/day or higher reverses the benefit, and I feel as if I relapsed. Remission does not happen for me at 300 mg/day.
About 20 years ago, Harvard conducted a study of the addition of low-dosage (300-600 mg/day) of lithium added to Prozac. They reported a statistically significant increase in response rate. However, the other treatment arm showed that increasing the dosage of Prozac to 60 mg/day rather than adding lithium produced a greater response rate.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.The only thing necessary for the triumph of evil is that good men do nothing.
poster:SLS
thread:1122216
URL: http://www.dr-bob.org/babble/20230117/msgs/1122217.html